A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients

Por Maryam Hafizi, Somayeh Kalanaky, Hassan moaiery, Maryam Khayamzadeh, Sajad Noorian, Vahid Kaveh, Behrooz Gharib, Hossein Foudazi, Mohsen Razavi, Arash Jenabian, Saeid Salimi, Mohammad Mahdi Adib Sereshki, Hamid Reza Mirzaei, Afshin Zarghi, Saideh Fakharzadeh, Mohammad Hassan Nazaran, Mohammad Esmaeil Akbari
Publicado em 2019-04-01